First SHANK3-deficient primate model
By Geraldine Bliss, Director, Phelan-McDermid Syndrome Foundation July 28, 2017 Over the last several years there have been many important…
Posts about advances in Phelan-McDermid syndrome research
By Geraldine Bliss, Director, Phelan-McDermid Syndrome Foundation July 28, 2017 Over the last several years there have been many important…
Ninety percent of individuals with Phelan-McDermid Syndrome have sleep disturbances, according to the results of a Stanford University study. However, only 22…
Twenty-one rare epilepsy organizations have joined forces with the Epilepsy Foundation, Research Triangle Institute, Columbia University and New York University to…
Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: Case Report Read…
Scientists at the University at Buffalo have identified the mechanisms behind a genetic mutation that produces certain autistic behaviors in mice,…
The hormone oxytocin is proceeding into clinical trials for people with Phelan-McDermid syndrome, researchers revealed yesterday at the 2015 International Meeting for…
PMSF mom Megan O’Boyle and her daughter, Shannon, is featured in this piece in Forbes. She’s addressing a topic many parents…
EU-AIM leader talks about autism, finding the elusive SHANK3 mutation and whether PMS cases are common Dr. Thomas Bourgeron is one…
Autism BrainNet is composed of a network of scientific institutions that follow the high standards set by Autism BrainNet to collect,…